5/5/2021 - The Jeanne Marie Lusher Predoctoral Diversity Fellowship (JML) seeks research applicants from communities of color and/or nationally underrepresented groups with the aim of increasing diversity in benign hematology research and practice.  The goal of JML is to identify, recruit and retain researchers and clinicians early in their career and assist them in establishing themselves in this field. The scope of this fellowship is broad and includes a range of topics from pre-clinical or basic science research to translational science regarding the biochemical, genetic, or hematologic aspects of inherited blood disorders including but not limited to hemophilia, von Willebrand disease, sickle cell disease, thalassemia, or hereditary hemorrhagic telangiectasia to health inequities faced by the inherited blood disorders community, joint disease/orthopedics, women’s health, pain management, or other therapeutics modalities pertaining to blood disorders. Questions? Contact NHF's Research Department [email protected] for further details. For more info, CLICK HERE Funding amount: $52,000 a year for three years, starting in Fall 2021 Letter of Intent Due: July 5th, 2021 at 11:59 PM EST Application Deadline: August 16th, 2021 at 9:00 PM EST

National Hemophilia Foundation (NHF)
Jeanne Marie Lusher Predoctoral Diversity Fellowship

 

The Jeanne Marie Lusher Predoctoral Diversity Fellowship (JML) seeks research applicants from communities of color and/or nationally underrepresented groups with the aim of increasing diversity in benign hematology research and practice. 

The goal of JML is to identify, recruit and retain researchers and clinicians early in their career and assist them in establishing themselves in this field. The scope of this fellowship is broad and includes a range of topics from pre-clinical or basic science research to translational science regarding the biochemical, genetic, or hematologic aspects of inherited blood disorders including but not limited to hemophilia, von Willebrand disease, sickle cell disease, thalassemia, or hereditary hemorrhagic telangiectasia to health inequities faced by the inherited blood disorders community, joint disease/orthopedics, women’s health, pain management, or other therapeutics modalities pertaining to blood disorders.

Questions? Contact NHF's Research Department [email protected] for further details.

For more info, CLICK HERE

Funding amount: $52,000 a year for three years, starting in Fall 2021

Letter of Intent Due: July 5th, 2021 at 11:59 PM EST

Application Deadline: August 16th, 2021 at 9:00 PM EST

 

top